BASi® Press Releases

Document Date Document Link
11/01/2018 BASi Names John E. Sagartz Chief Strategy Officer
10/17/2018 BASi Breaks Ground on Expansion of GLP Toxicology Facility in Indiana
07/09/2018 BASi Announces Appointment of John E. Sagartz to Board of Directors
07/02/2018 Seventh Wave Laboratories Combine Operations to Provide Broader Solutions and Greater Scientific Expertise to Clients
04/30/2018 James Bourdage to Retire as BASi VP of Bioanalytical Operations; Michael Baim Named as Successor
04/04/2018 BASi and Phlebotics Form Strategic Alliance; Continuing a Commitment to Automated Blood Sampling
03/27/2018 Bolstering Preclinical PK/PD Operations: BASi Hires Karen L. Rogers, DVM, DACLAM, CPIA as Attending Veterinarian
12/12/2017 BASi Announces Enhanced Bioequivalence Capabilities
11/13/2017 Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana
10/03/2017 Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of In Vivo Products and Services
09/19/2017 BASi Strengthens Preclinical PK/PD Leadership With the Hiring of James E. Burleigh as Director of Operations, Preclinical PK/PD
09/06/2017 BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology
08/28/2017 BASi Announces New Universal Caging System for Automated Sampling With Focus on Researcher-Friendly Design
08/03/2017 BASi Announces Election of R. Matthew Neff to the Board of Directors
07/31/2017 BASi Signs Reseller Agreement With LABEX of MA for Refurbished Culex® Automated Blood Sampling Systems
06/27/2017 BASi Completes Refinancing of Senior Secured Credit Facilities
06/20/2017 BASi Names Dr. Gregory C. Davis to Board of Directors
06/07/2017 BASi Announces Validated 'SEND' Capabilities and Compliance With FDA's Standard for Exchange of Nonclinical Data
05/01/2017 BASi Announces Appointment of Dr. Peter T. Kissinger as Scientific Advisor
03/08/2017 BASi Names Philip Downing Senior Vice President of Preclinical Services
12/21/2016 BASi Names Alan Loch Director of Business Development
08/25/2016 BASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System
07/27/2016 BASi Expands Electrochemical Offerings by Partnering with PalmSens BV
05/11/2016 BASi Announces Appointment of New Chief Financial Officer
04/14/2016 BASi Launches New Website and E-Catalogue
03/29/2016 BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™
02/04/2016 BASi Awards Raturn® Systems for Optogenetic Research
12/14/2015 BASi Names Wendy Perrow to Board of Directors
07/14/2015 BASi Announces Enhancements to the Company's Laboratory Information Management System (LIMS)
03/17/2015 BASi Names Philip A. Downing Vice President of Preclinical Services
02/12/2015 BASi Expands Scientific Expertise with the Hiring of Srini Jayaraman, Ph.D., Principal Investigator Discovery and Braden M. Kemmerling, D.V.M., Attending Veterinarian for Preclinical Services
12/02/2014 BASi’s Culex® L Large Animal Sampling System Combines an Ideal Model with an Ideal Tool for Improved Drug Development Research
06/12/2014 BASi Names Jeffrey Potrzebowski CFO and James Bourdage VP Bioanalytical Operations
05/30/2014 BASi Hosts In Vivo Drug Discovery Workshop at UCLA
10/16/2013 BASi Signs Preferred Provider Agreement with G1 Therapeutics
05/02/2013 BASi Launches Innovative Glucose Monitoring Project with Pinnacle Technology
12/18/2012 BASi to Release Fourth Quarter & Fiscal 2012 Results Thursday, December 27, 2012; Conference Call & Webcast Set For 11:00 a.m. EDT